CASP9 and colorectal carcinoma: The detection of cleaved effectors caspase-3/7, caspase-9, and caspase-8 in Compound 5a-treated CRC HT29 and SW620 cells would verify and validate the apoptotic status, the intrinsic and death-receptor-dependent pathway activation, and respectively.